Evidence map›Paper›PMID 30282637›Full record

ArticleThe Journal of biological chemistry2018

MicroRNA-451a in extracellular, blood-resident vesicles attenuates macrophage and dendritic cell responses to influenza whole-virus vaccine.

Masaaki Okamoto, Yoshimi Fukushima, Takahisa Kouwaki, Takuji Daito, Michinori Kohara, Hiroshi Kida, Hiroyuki Oshiumi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Differential Effect of Extracellular Vesicles Derived fromInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Masaaki OkamotoFrom the Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556.
Yoshimi FukushimaFrom the Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556.
Takahisa KouwakiFrom the Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556.
Takuji Daitothe Research Center for Zoonosis Control, GI-CoRE Global Station for Zoonosis Control, Hokkaido University, North 20, West 10 Kita-ku, Sapporo 001-0020.
Michinori Koharathe Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Kamikitazawa, Setagaya-ku, Tokyo 156-8506, and.
Hiroshi Kidathe Research Center for Zoonosis Control, GI-CoRE Global Station for Zoonosis Control, Hokkaido University, North 20, West 10 Kita-ku, Sapporo 001-0020.
Hiroyuki OshiumiFrom the Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, oshiumi@kumamoto-u.ac.jp.ORCID 0000-0003-1567-8722
Kumamoto University · JPHokkaido University · JPJapan Science and Technology Agency · JPTokyo Institute of Psychiatry · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The innate immune system is important for the efficacy of vaccines, but excessive innate immune responses can cause adverse reactions after vaccination. Extracellular vesicles (EVs) are enriched in the blood and can deliver functional RNAs, such as microRNAs (miRNAs), to recipient cells, thereby mediating intercellular communication. However, the role of EVs in controlling the innate immune responses to vaccines has not been fully elucidated. Here, we found that miR-451a is abundant in human serum EVs and that its presence in blood-circulating EVs affects the innate immune responses of macrophages and dendritic cells to inactivated whole-virus vaccines (WV) against influenza. miR-451a in human serum EVs was stable for a week in healthy subjects, and its levels gradually fluctuated over several months. miR-451a within serum EVs was internalized into serum-cultured macrophages and dendritic cells and reduced endogenous 14-3-3ζ protein levels and decreased the expression of type I IFN and interleukin 6 in response to WV stimulation. miR-451a levels in blood-circulating EVs were positively correlated with intracellular miR-451a levels in mouse splenic CD11c

Indexed as

14-3-3 ProteinsAdultAnimalsCell LineDendritic CellsExocytosisExtracellular VesiclesHumansImmunity, InnateInfluenza VaccinesMacrophagesMiceMicroRNAsReverse Transcriptase Polymerase Chain Reaction14-3-3 ProteinsInfluenza VaccinesMicroRNAsMIRN451 microRNA, humanantiviral responsedendritic cellextracellular vesiclesinflammationinfluenza virusinnate immunitymacrophagemicroRNA (miRNA)vaccinevirus

Identifiers

PMID30282637
PMCPMC6290151
OpenAlexW2895764260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.